BioSpace.com News

Maxygen, Inc. Announces Board Decision to Dissolve the Company

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Maxygen Announces Board Decision to Dissolve the Company

SAN MATEO, Calif.--(BUSINESS WIRE)-- Maxygen, Inc. (MAXY), a biopharmaceutical company, today announced that its...

Allon Therapeutics, Inc. Filing for Bankruptcy

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Allon Announces the Filing of a Proposal with Creditors and Reorganization

VANCOUVER, May 30, 2013 -- /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company...

GenVec Inc. Board Votes to Dissolve Company

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The board of GenVec Inc. has voted to liquidate and dissolve the struggling Gaithersburg biotech, it announced Tuesday in a securities filing. The move follows a string of setbacks for GenVec, which three years...

Allenex AB: ONCOlog Has Filed for Bankruptcy

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Since the autumn of 2012, the Board of ONCOlog has worked to find buyers for the sale of the entire company or its assets. However, these efforts have not been successful...

Commonwealth Biotechnologies, Inc. Says It has Emerged From Chapter 11

Thu, 18 Apr 2013 12:00:00 AM GMT

RICHMOND, Va.--(BUSINESS WIRE)-- Commonwealth Biotechnologies, Inc. (OTC Pink:CBTE) (CBI) announced today that its Plan of Reorganization from Chapter 11 bankruptcy proceedings has become effective April 15, 2013.

Pursuant to such plan, CBI is currently in the process of finalizing definitive documentation with HedgePath, LLC (HedgePath), a drug development company focused on cancer therapies...

PolyMedix Inc. of Radnor Files for Chapter 7 Bankruptcy Protection

Tue, 02 Apr 2013 12:00:00 AM GMT

PolyMedix, Inc., a small biotech company in Radnor, Pa., filed for Chapter 7 bankruptcy protection Monday, according to a filing with the Securities and Exchange Commission. In January, PolyMedix replaced then-chief executive officer Nicholas Landekic with chief financial officer Edward F. Smith as interim CEO. Smith resigned Monday, according to the SEC filing. A company spokeswoman did not return...

After Bankruptcy, PRACS Institute (Formerly known as Cetero Research) Lays Off Workers

Tue, 26 Mar 2013 12:00:00 AM GMT

PRACS Institute, the contract research organization that emerged from troubled Cary CRO Cetero Research, was closed this week less than a year after emerging from bankruptcy and this time it looks like the company has dosed its last patient. The CRO laid off all its workers and shut down operations at its Fargo, N.D. headquarters, Toronto and St. Louis, according to news reports in each of those three...

Biovest International, Inc. Files for Bankruptcy

Fri, 08 Mar 2013 12:00:00 AM GMT

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Mar 7, 2013 - Biovest International, Inc. (OTCQB:BVTI) today reported that the Company has filed a petition for protection under Chapter 11 of the U.S. Bankruptcy Code and a Plan of Reorganization (the Plan) seeking to implement a restructuring of its balance sheet that would eliminate approximately $44 million in senior secured debt held by Laurus/Valens...

Battered Helicos BioSciences Corporation Files for Chapter 11

Fri, 16 Nov 2012 12:00:00 AM GMT

Battered by years of rough financial sledding and tough competition from rival next-generation sequencing companies, Helicos Biosciences filed Thursday for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code. In its filing (Case 12-19091) in U.S. Bankruptcy Court for the District of Massachusetts, Helicos listed $15.478 million in liabilities and only $3.503 million in assets. On...

Myrexis, Inc. to Dissolve the Company and Liquidate Assets

Tue, 13 Nov 2012 12:00:00 AM GMT

SALT LAKE CITY, Nov. 9, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to dissolve the Company and liquidate its assets. In connection with the dissolution and liquidation, which is subject...

Inspiration Biopharmaceuticals Files for Chapter 11

Wed, 31 Oct 2012 12:00:00 AM GMT

Assets to Be Sold Comprise Basis for a Global Hemophilia Business Ipsen to Provide DIP Financing through the Sale Process

Inspiration Biopharmaceuticals, Inc. (Inspiration), a biopharmaceutical company dedicated solely to the development of products for hemophilia, today announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code. Inspiration is seeking a strategic...

Nutra Pharma Corp. Faces Involuntary Bankruptcy

Wed, 05 Sep 2012 12:00:00 AM GMT

South Florida Business Journal by Paul Brinkmann, Reporter

A group of creditors for a Coral Springs-based biotech company, Nutra Pharma Corp., is asking a judge to put the company into Chapter 7 bankruptcy.

Nutra Pharma (Pink Sheets: NPHC) has focused mainly on marketing a pain reliever product called Nyloxin, which contains ingredients derived from cobra venom.

Bankruptcy...

KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes

Mon, 06 Aug 2012 12:00:00 AM GMT

ST. LOUIS, Aug. 4, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/ KVb) ("K-V" or "the Company") and certain of its domestic subsidiaries today filed voluntary Chapter 11 petitions under the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York

After a Long Fight to Survive, Genta Incorporated Files for Chapter 7

Thu, 02 Aug 2012 12:00:00 AM GMT

On August 2, 2012, Genta Incorporated (the Company), intends to file a voluntary petition for relief under Chapter 7 of the United States Bankruptcy Code (the Code) in the United States Bankruptcy Court for the District of Delaware (the Filing).

Biolex Therapeutics Execs Gone Before Filing for $38 Million Bankruptcy

Mon, 09 Jul 2012 12:00:00 AM GMT

Triangle Business Journal by Lauren K. Ohnesorge, Staff Writer

Prior to filing its bankruptcy papers, Biolex tried cutting expenses by laying off the companys two top executives, CEO Jan Turek and CFO Dale Sander, the filing reveals. They were terminated on May 15.

The only executives not listed in the filing as having been terminated were Chief Medical Officer Walker Long and...

"Corrupt" Lab Practices Pushes CRO Firm Cetero Research Into Bankruptcy

Mon, 26 Mar 2012 12:00:00 AM GMT

Contract research firm Cetero filed for bankruptcy protection early on Monday, court documents show, months after the U.S. drug regulator put the company on notice for faking documents and manipulating drug samples. In July last year, the U.S. Food and Drug Administration (FDA) said two 2010 inspections, an internal company investigation and a third-party audit uncovered "significant instances of misconduct...

Neurologix, Inc. Files to Liquidate Under Chapter 7 Bankruptcy

Mon, 19 Mar 2012 12:00:00 AM GMT

Neurologix Inc. (NRGX), a clinical-stage developer of gene therapies for disorders of the brain and central nervous system, filed for protection under the liquidation provision of the U.S. Bankruptcy Code. The Fort Lee, New Jersey-based company listed assets of $1.2 million and debt of $12.9 million as of March 6 in Chapter 7 documents filed today in U.S. Bankruptcy Court in Wilmington, Delaware. Chapter...

Laboratories Thissen SA Files for Bankruptcy

Wed, 16 Nov 2011 12:00:00 AM GMT

15 November 2011 -- Laboratoires Thissen SA (the site), the Belgian subsidiary of NextPharma Technologies Holding Limited, will file a petition for bankruptcy with the Commercial Court of Nivelles in Belgium (the Court). No other companies in the NextPharma group are affected by this decision.

After the bankruptcy filing it is anticipated that the Court will shortly appoint a Receiver...

Simulations Plus Submits Bid in Chapter 11 Bankruptcy Proceedings for Assets of Entelos, Inc.

Tue, 20 Sep 2011 12:00:00 AM GMT

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has submitted a bid to purchase substantially all of the assets of Entelos, Inc., in an auction supervised by and in accordance with certain bidding procedures approved by the United States Bankruptcy Court...

Transdel Pharmaceuticals, Inc. Files for Chapter 11, Agrees to Sell Lead Drug Candidate to Cardium Therapeutics, Inc.

Tue, 28 Jun 2011 12:00:00 AM GMT

June 27, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain. The business assets would...

Hawaii Biotech, Inc. Exits Bankruptcy

Tue, 21 Jun 2011 12:00:00 AM GMT

(Click here for details)
Hawaii Biotech CEO Elliot Parks and...

Molecular Insight Pharmaceuticals, Inc. Announces Confirmation of Plan of Reorganization

Mon, 09 May 2011 12:00:00 AM GMT

Molecular Insight Pharmaceuticals, Inc. (OTCQB: MIPIQ) (Pinksheets:MIPIQ - News), today announced that at a hearing held on May 5, 2011, the U.S. Bankruptcy Court for the District of Massachusetts confirmed the Company's Amended Plan of Reorganization (the "Plan"). Molecular Insight is scheduled to emerge from Chapter 11 as a fully restructured company by late May 2011.

As confirmed, the...

Advanced Life Sciences Holdings, Inc. Suspends Operations

Fri, 06 May 2011 12:00:00 AM GMT

Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has suspended operations and terminated its staff due to its severe lack of liquidity.

(Logo:

Ambrilia Biopharma Inc. Announces That it Will Seek Permission to Terminate Protection and File for Bankruptcy

Fri, 08 Apr 2011 12:00:00 AM GMT

MONTREAL, QUEBEC--(Marketwire - 04/08/11) - Ambrilia announces that its Directors have approved resolutions whereby the Corporation will seek permission to terminate the protection granted by the Superior Court pursuant to the Companies' Creditors Arrangement Act (Canada) ("CCAA") and, upon permission of the Court being granted, the Corporation will file for bankruptcy pursuant to the Bankruptcy and...

Peptimmune, Inc. Files Under Chapter 7

Wed, 23 Mar 2011 12:00:00 AM GMT

Boston Business Journal -- Peptimune, Inc, a privately held biotechnology company in Cambrige, Mass., has filed under Chapter 7 of the bankruptcy code.

The filing came after the company failed to raise a proposed $35 million round of venture capital funding, an executive said. The company had shrunk to five employees from more than 50 last year as resources dwindled.

According to...

Molecular Insight Pharmaceuticals, Inc. Accepts Alternative Transaction Proposal and Files Amended Plan of Reorganization

Wed, 09 Mar 2011 12:00:00 AM GMT

CAMBRIDGE, MA--(Marketwire - 03/08/11) - Molecular Insight Pharmaceuticals, Inc. (Pinksheets:MIPIQ - News) (Pinksheets:MIPIQ - News) today announced that it had accepted an alternative transaction proposal regarding its restructuring and filed an amended plan of reorganization and an amended disclosure statement with the U.S. Bankruptcy Court for the District of Massachusetts in connection with the...

MetaMorphix Announces Sale Under Bankruptcy Code

Mon, 07 Feb 2011 12:00:00 AM GMT

CALVERTON, Md., Feb. 4, 2011 /PRNewswire/ -- MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.

The...

Isis Pharmaceuticals, Inc. Spinoff Altair Therapeutics Shut Down After Mid-Stage Asthma Study Fails

Fri, 04 Feb 2011 12:00:00 AM GMT

Xconomy -- San Diego-based Altair Therapeutics, a spinoff from Isis Pharmaceuticals (NASDAQ: ISIS), has shut down operations after the startups only drug candidate failed in a mid-stage clinical trial against asthma, Xconomy has learned.

Angiotech Pharmaceuticals, Inc. Announces U.S. Chapter 15 Filings in Connection with Previously Announced Proceedings

Tue, 01 Feb 2011 12:00:00 AM GMT

VANCOUVER, Jan. 31 /CNW/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") today announced that, in connection with its previously announced actions taken under the Companies' Creditors Arrangement Act (the "CCAA Proceedings") before the Supreme Court of British Columbia (the "Canadian Court"), it and each of its subsidiaries that commenced the CCAA Proceedings filed a voluntary petition...

Molecular Insight Pharmaceuticals, Inc. Faces Uncertain Future in Chapter 11

Mon, 31 Jan 2011 12:00:00 AM GMT

CAMBRIDGE, MA--(Marketwire - January 26, 2011) - Molecular Insight Pharmaceuticals, Inc. (OTCQB: MIPIQ) (PINKSHEETS: MIPIQ), today announced that it has received approval from the U.S. Bankruptcy Court for the District of Massachusetts of...

Canada's Angiotech Pharmaceuticals, Inc. to File for Bankruptcy

Fri, 28 Jan 2011 12:00:00 AM GMT

Jan 28 (Reuters) - Angiotech Pharmaceuticals Inc (ANP.TO) said it will file for bankruptcy protection under Canada's Companies' Creditors Arrangement Act to cut $250 million of its debt.

Molecular Insight Pharmaceuticals, Inc. Files for Chapter 11 After Bondholders Reject $45 Million Rescue Package from

Fri, 10 Dec 2010 12:00:00 AM GMT

CAMBRIDGE, MA--(Marketwire - December 09, 2010) - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI), a biopharmaceutical company discovering and developing targeted therapeutic and imaging radiopharmaceuticals for use in oncology, today announced that it has entered into a $45-million financing commitment...

Accentia, Inc., Biovest International, Inc. Emerges from Chapter 11 Reorganization

Wed, 17 Nov 2010 12:00:00 AM GMT

TAMPA, Fla.--(BUSINESS WIRE)-- Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI) announced that, effective today, the Company and its majority-owned subsidiary, Biovest International, Inc. (OTCQB: BVTI), have both successfully completed their reorganizations. Pursuant to their respective Plans of Reorganization approved by the bankruptcy court, Accentia and Biovest have now formally exited Chapter...

Accentia Biopharmaceuticals, Biovest International, Inc. Announces Confirmation of Plan of Reorganization As It Emerges From Chapter 11

Thu, 28 Oct 2010 12:00:00 AM GMT

TAMPA, Fla.--(BUSINESS WIRE)-- Accentia Biopharmaceuticals, Inc. (OTCQB: ABPIQ) today announced that at a hearing held on October 27, 2010, the Companys Plan of Reorganization was confirmed (i.e., approved) by the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. Accentia is scheduled to emerge from Chapter 11 as a fully restructured company by mid-November 2010.

As...

Surefil LLC Emerges from Chapter 11

Thu, 23 Sep 2010 12:00:00 AM GMT

GRAND RAPIDS, Mich., Sept. 23 /PRNewswire/ -- Surefil, a contract manufacturer of liquid-fill products for the personal care, home care, oral care, medical industries, and energy drinks, emerged from Chapter 11 protection with Federal Court approval on September 15, 2010. The company was able to attract ABACO Partners, LLC a

ConjuChem Biotechnologies Inc. Announces Bankruptcy Act Filing; Directors and Officers of Company Resign

Thu, 22 Jul 2010 12:00:00 AM GMT

MONTREAL, July 21 /CNW/ - ConjuChem Biotechnologies Inc. ("ConjuChem" or the "Company") announced today that it has filed a voluntary assignment in bankruptcy under the Bankruptcy and Insolvency Act (Canada) in order to effect an orderly liquidation of its assets, property and operations. The protection of the Court granted under the Companies' Creditors Arrangement Act (Canada) ended on July 19, ...

AutoImmune, Inc. Files Certificate of Dissolution and Completes Sale of Colloral LLC Business; Trading of Common Stock to Cease After June 30, 2010

Thu, 01 Jul 2010 12:00:00 AM GMT

PASADENA, Calif., June 30 /PRNewswire-FirstCall/ -- AutoImmune Inc. (Pink Sheets: AIMM) today announced that it filed its Certificate of Dissolution with the Delaware Secretary of State on June 30, 2010 (the "Final Record Date"), in accordance with...

Neose Technologies, Inc. Announces Final Liquidating Distribution

Thu, 10 Jun 2010 12:00:00 AM GMT

WILLOW GROVE, Pa.--(BUSINESS WIRE)--Neose Technologies, Inc. (Trading symbol: NTEC.PK) today announced that, in accordance with the Plan of Complete Liquidation and Dissolution (the Plan of Liquidation) approved by its stockholders on January 26, 2009, its Board of Directors has approved a final liquidating distribution (the Final Liquidating Distribution) in the amount of $0.0121 per share of...

Exiqon A/S is Closing Down Operations at Oncotech

Mon, 07 Jun 2010 12:00:00 AM GMT

VEDBAEK, Denmark, June 4, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ - News) today announced that its wholly owned subsidiary, Oncotech, Inc. ("Oncotech"), will be pursuing an out-of-court liquidation conducted by a common law Assignment for the Benefit of Creditors.On 17 December 2009, Exiqon announced its intention to divest Oncotech. Exiqon has since been engaged in discussions with numerous...

Accentia, Inc. Files Plan of Reorganization; Restructuring Supports Plans to Advance Promising Multiple Sclerosis Therapy into Late-Stage Clinical Trial

Tue, 01 Jun 2010 12:00:00 AM GMT

TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. today announced that the Company filed its proposed Plan of Reorganization (Plan) with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. With this filing, Accentia is positioned to emerge from Chapter 11 protection this summer as a fully restructured company. Upon Court-ordered confirmation, the Plan is expected...

Cobalis Corp. Files Form of Order with US Bankruptcy Court Signaling Emergence from Bankruptcy

Wed, 26 May 2010 12:00:00 AM GMT

IRVINE, Calif., May 26 /PRNewswire/ -- Cobalis Corp announced today that the Company's attorneys have submitted a Form of Order consistent with the United States Bankruptcy Court's ruling of April 7, 2010 confirming the debtor's plan of reorganization.

Upon entry of the Order by the Court, Cobalis Corp will have officially emerged from bankruptcy, and will immediately commence the launch...

TLC Vision Corp. Completes Financial Restructuring; Emerges From Chapter 11 as Newly Reorgnized Private Company

Thu, 20 May 2010 12:00:00 AM GMT

ST. LOUIS, MO--(Marketwire - May 20, 2010) - TLC Vision (USA) Corporation (the "Company"), North America's premier eye care services company, announced today that it has officially emerged from Chapter 11 as a newly reorganized, private company. The Company's Plan of Reorganization (the "Plan"), which was confirmed by the U.S. Bankruptcy Court on May 6, 2010 and subsequently...

Biovest International, Inc. Files Plan of Reorganization; Company Positioned to Emerge from Chapter 11 This Summer Fully Restructured

Mon, 17 May 2010 12:00:00 AM GMT

TAMPA, Fla. and MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (Pink Sheets: BVTI - News) today announced that the Company filed its proposed Plan of Reorganization (Plan) with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. With this filing, Biovest is positioned to emerge from Chapter 11 protection this summer as a fully restructured company. Upon Court...

MiddleBrook Pharmaceuticals, Inc. Files for Bankruptcy

Mon, 03 May 2010 12:00:00 AM GMT

WESTLAKE, Texas, Apr 30, 2010 (BUSINESS WIRE) -- MiddleBrook Pharmaceuticals, Inc. has filed a voluntary petition (the "Petition") for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). MiddleBrook will continue to manage and operate its business and assets during the pendency of the bankruptcy case...

U.S. Federal Bankruptcy Court Confirms Cobalis Corp.'s Plan of Reorganization

Mon, 12 Apr 2010 12:00:00 AM GMT

IRVINE, CA--(Marketwire - 04/12/10) - Federal Bankruptcy Court Judge Theodor C. Albert, of the Central District of California issued his final ruling on April 7, 2010, handing Cobalis Corp (Pinksheets:CLSC - News) a resounding victory by confirming Cobalis Corp's plan of reorganization. Upon confirmation, Cobalis will officially emerge from bankruptcy, with requirements to pay its creditors over a...

Haemacure Corporation Gets Canada Court OK to Sell Assets to Angiotech Pharmaceuticals, Inc.

Mon, 22 Mar 2010 12:00:00 AM GMT

MONTREAL, March 22 /PRNewswire/ - Haemacure Corporation (TSX:HAE.to - News) announces that it has obtained authorization from the Superior Court of the Province of Qubec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

The sale...

Neuropharm Group plc to Mull Voluntary Liquidation to Return Cash

Wed, 10 Mar 2010 12:00:00 AM GMT

Neuropharm Group plc (AIM: NPH), a speciality pharmaceutical company focused on neurodevelopmental disorders, today provides an update to shareholders on developments in relation to the proposed sale or merger of the Company.

Neuropharm has been in discussions with a number of parties since it entered an offer period on 3 November 2009 and announced that it was pursuing a proposed sale or...

AutoImmune, Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution

Tue, 09 Mar 2010 12:00:00 AM GMT

PASADENA, Calif., March 9 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today announced that its Board of Directors has determined, after consideration of potential strategic alternatives, that it is in the best interests of the Company and its stockholders to liquidate the Company's assets and to dissolve the Company. In connection with the liquidation, the Company intends...

Announcing the New deCODE genetics, Inc.; Company Emerges from Bankruptcy

Mon, 25 Jan 2010 12:00:00 AM GMT

Luna Innovations Inc. Emerges from Chapter 11 Reorganization

Wed, 13 Jan 2010 12:00:00 AM GMT

Anesiva, Inc. Says to Seek Bankruptcy After Deal Fails

Mon, 04 Jan 2010 12:00:00 AM GMT

Vion Pharmaceuticals Files for Chapter 11 Bankruptcy After FDA Rejects Drug

Fri, 18 Dec 2009 12:00:00 AM GMT

Hawaii Biotech, Inc. Files for Bankruptcy

Tue, 15 Dec 2009 12:00:00 AM GMT

deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets

Tue, 17 Nov 2009 12:00:00 AM GMT

Altus Pharmaceuticals Inc. Files for Chapter 7 Bankruptcy

Thu, 12 Nov 2009 12:00:00 AM GMT

Boston Business Journal -- Beleaguered drug maker Altus Pharmaceuticals Inc. of Waltham filed Wednesday for Chapter 7 bankruptcy a step that usually results in liquidation of a companys assets.

Nyer Medical Group, Inc. Announces Agreements to Sell Certain Assets to and Sell Operating Subsidiary's Stock to Investors; to Liquidate Following Transactions

Mon, 26 Oct 2009 12:00:00 AM GMT

HOLLISTON, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc., announced today that D.A.W., Inc., a wholly-owned subsidiary of Nyer which does business under the name Eaton Apothecary, and Nyer entered into a definitive agreement with Walgreen Eastern Co., Inc. for the sale of a substantial portion of DAW's operating assets, including prescription files and inventory...

La Jolla Pharmaceutical Company to Seek Stockholders' Approval of Dissolution

Thu, 15 Oct 2009 12:00:00 AM GMT

Altus Pharmaceuticals Inc. to Shut Doors; Firm to Let Go of Employees by October

Fri, 18 Sep 2009 12:00:00 AM GMT

Protein Sciences Corporation: Bankruptcy Court Delaware Dismisses Involuntary Bankruptcy Case

Tue, 15 Sep 2009 12:00:00 AM GMT

Neurobiological Technologies, Inc. Board Approves Liquidation Plan

Tue, 01 Sep 2009 12:00:00 AM GMT

La Jolla Pharmaceutical Company Plans Liquidation

Wed, 05 Aug 2009 12:00:00 AM GMT

Ambrilia Biopharma Inc. to File for Creditor Protection

Fri, 31 Jul 2009 12:00:00 AM GMT

Argolyn Bioscience, Inc.'s Final Failure; Company in Chapter 7 Bankruptcy Dissolution

Mon, 27 Jul 2009 12:00:00 AM GMT

Triangle Business Journal -- Just six months ago and two years after attracting enough investor interest to gain a commitment of $15.8 million in venture financing, Argolyn Bioscience was preparing for clinical trials of its first product.

Luna Innovations Inc. Files for Chapter 11 Reorganization

Fri, 17 Jul 2009 12:00:00 AM GMT

Biopure Corporation Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code

Fri, 17 Jul 2009 12:00:00 AM GMT

Oscient Pharmaceuticals Corporation Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million

Tue, 14 Jul 2009 12:00:00 AM GMT

TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust

Fri, 10 Jul 2009 12:00:00 AM GMT

NEW YORK, July 10 /PRNewswire-FirstCall/ -- TransTech Services Partners, Inc.("Company") today announced that its stockholders voted at its special meeting held on July 8, 2009 to approve the plan of liquidation of the Company.

The board of directors of the Company expects that the trustee of the Company's trust account will shortly make a final liquidating distribution of the...

Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

Mon, 22 Jun 2009 12:00:00 AM GMT

EXTON, Pa., June 19 /PRNewswire/ -- Isolagen(TM), Inc. announced on June 16, 2009, that the Company and Isolagen Technologies, Inc., the Company's wholly owned subsidiary, each filed a voluntary petition for reorganization under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware in Wilmington. The Company and Isolagen Technologies...

EDEN Bioscience Announces Voluntary Delisting From and Filing of Articles of Dissolution

Fri, 19 Jun 2009 12:00:00 AM GMT

US Biotech Isolagen, Inc. Files for Bankruptcy Protection

Tue, 16 Jun 2009 12:00:00 AM GMT

Northstar Neuroscience, Inc. Announces Plan for Delisting and Filing of Articles of Dissolution

Fri, 12 Jun 2009 12:00:00 AM GMT

SEATTLE, June 12, 2009 (GLOBE NEWSWIRE) -- Northstar Neuroscience, Inc. (Nasdaq:NSTR) announced today that is has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. On June 22, 2009, Northstar will file with the Securities and Exchange Commission and NASDAQ a Form 25 relating to the delisting of...

Genaera Corporation Board Votes to Dissolve Company

Fri, 12 Jun 2009 12:00:00 AM GMT

Northfield Laboratories to Liquidate Under Chapter 11

Tue, 02 Jun 2009 12:00:00 AM GMT

Reuters -- Northfield Laboratories, whose human red blood cell substitute was denied U.S. regulatory approval, filed for bankruptcy protection on Monday to liquidate its assets.

TorreyPines Therapeutics, Inc. Board Approves Liquidation

Mon, 01 Jun 2009 12:00:00 AM GMT

EDEN Bioscience Announces Shareholders' Approval of Plan of Dissolution and Liquidation

Thu, 21 May 2009 12:00:00 AM GMT

Prospect Therapeutics, Inc. Assigns All Its Assets for the Benefit of Its Creditors

Wed, 13 May 2009 12:00:00 AM GMT

WELLESLEY HILLS, Mass., May 12 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that assets of Prospect Therapeutics, Inc. ("Prospect") have been assigned to him for the benefit of Prospect's creditors.

Prospect's lead product candidate, GCS-100, is a carbohydrate molecule designed to inhibit the activity of galectin-3, a protein found in high concentration in...

Northfield Laboratories Terminates All of its Operational and Staff Employees and Shuts Down

Mon, 11 May 2009 12:00:00 AM GMT

EVANSTON, Ill.--(BUSINESS WIRE)--Northfield Laboratories Inc. announced today that it has terminated the employment of substantially all of its operational and staff employees at its manufacturing facility in Mount Prospect, Illinois and headquarters in Evanston, Illinois.

About Northfield Laboratories

Northfield Laboratories is developing a hemoglobin-based oxygen-carrying red...

Targeted Genetics Corporation, Mainstay of Gene Therapy, Faces Likely Shutdown

Fri, 08 May 2009 12:00:00 AM GMT

Xconomy -- Targeted Genetics, one of the diehards in the field of gene therapy, appears to be near the end of the road. The Seattle-based biotech company said if it is unable to improve its finances by the end of next month, We plan to begin the process of ceasing operations, seeking bankruptcy protection or otherwise winding up our business, according to its quarterly filing with the SEC.

Genaera Corporation Shutting Down; Company Announces Approval of Plan of Liquidation and Dissolution by Board of Directors

Thu, 30 Apr 2009 12:00:00 AM GMT

PharmEng Unable to File Its 2008 Audited Annual Financial Statements and Closes Sydney Manufacturing Facility

Thu, 23 Apr 2009 12:00:00 AM GMT

TORONTO, ONTARIO--(MARKET WIRE)--Apr 23, 2009 -- PharmEng International Inc. (CDNX:PII.V - News) (the "Company"), announces that it will not be able to file its annual audited financial statements and the related MD&A and certifications of same (collectively, the "Annual Filings") by the filing deadline of April 30, 2009 as prescribed by National Instrument 51-102 - Continuous Disclosure Obligations...